Bone mineral density (DEXA) screening among men with prostate cancer: a missed opportunityProstate cancer is the most common cancer among men in the United States and the second leading cause of cancer death. The use of androgen-deprivation therapy (A...
Read More about Should men with prostate cancer receive DEXA screening?
The controversial decision by the United States Preventive Services Task Force (USPSTF) recommending against screening for prostate cancer with the prostate specific antigen (PSA) test has resulted in confusion for patients and physicians alike.Historically...
Read More about The Role of PSA Velocity in the Early Detection of Prostate Cancer
In May 2012, the United States Preventive Services Task Force finalized a controversial draft statement recommending against routine prostate specific antigen (PSA)-based screening for prostate cancer. Praised by some, and harshly criticized by others,...
Read More about Prostate Cancer: Is PSA Screening Worth the Trouble?
